Skip to main content
. 2017 Jul 1;8(48):83637–83649. doi: 10.18632/oncotarget.18906

Figure 6. Funnel plot of randomized controlled trials included in the meta-analysis for hazard ratios of progression-free survival.

Figure 6

CHE = chemotherapy. IPI = ipilimumab. TRE = tremelimumab. NIV = nivolumab. PEM = pembrolizumab. IPI_CHE = ipilimumab plus chemotherapy. IPI_NIV = ipilimumab followed by nivolumab. IPI_GP100 = ipilimumab plus glycoprotein 100. IPI_BUD = ipilimumab plus budesonide. IPI_SAR = ipilimumab plus sargramostim.